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Abstract Previous studies conducted in our laboratory showed
that transgenic medaka expressing cecropin B transgenes exhib-
ited resistant characteristic to fish bacterial pathogens,
Pseudomonas fluorescens and Vibrio anguillarum . To confirm
whether antimicrobial peptide gene will also exhibit anti-
bacterial and anti-viral characteristics in aquaculture important
fish species, we produced transgenic rainbow trout expressing
cecropin P1 or a synthetic cecropin B analog, CF-17, transgene
by sperm-mediated gene transfer method. About 30 % of fish
recovered from electroporation were shown to carry the trans-
gene as determined by polymerase chain reaction (PCR) ampli-
fication assay. Positive P1 transgenic fish were crossed to non-
transgenic fish to establish F1 transgenic founder families, and
subsequently generating F2, and F3 progeny. Expression of
cecropin P1 and CF-17 transgenes was detected in transgenic
fish by reverse transcription (RT)-PCR analysis. The distribution
of body sizes among F1 transgenic fish were not significantly
different from those of non-transgenic fish. Results of challenge
studies revealed that many families of F2 and F3 transgenic fish
exhibited resistance to infection by Aeromonas salmonicida and
infectious hematopoietic necrosis virus (IHNV). All-male homo-
zygous cecropin P1 transgenic families were produced by andro-
genesis from sperm of F3 heterozygous transgenic fish in one
generation. The resistant characteristic to A. salmonicida was
confirmed in progeny derived from the outcross of all-male fish
to non-transgenic females. Results of our current studies con-
firmed the possibility of producing disease-resistant homozygous
rainbow trout strains by transgenesis of cecropin P1 or CF-17
gene and followed by androgenesis.
Keywords Cecropin P1 . Antimicrobial peptide . Transgenic
rainbow trout . Disease resistant . Sperm-mediated gene
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Introduction
Cecropins, a family of small molecular weight basic peptides
with bactericidal activity, also known as antimicrobial peptide
(AMP), were first discovered in the hemolymph of diapausing
cecropia (Hyalophora cecropia) pupae following inoculation
with bacterial debris (Hultmark et al. 1980; Boman and
Hultmark 1987). Since then many cecropin-like antimicrobial
peptides have been identified and characterized from a wide
variety of organisms including nematode (Pillai et al. 2005),
invertebrates, vertebrates (for review, see Bulet et al. 2004)
and plants (Broekaert et al. 1995). Cecropins are first translat-
ed as prepropeptides containing 62 to 64 amino acid residues,
and then processed intracellularly into mature peptides of 35
to 37 amino acid residues prior to secretion into the circulation
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(Boman et al. 1991; Boman 1995). Due to their unique struc-
tural features, cecropins and cecropin-like peptides can be
readily incorporated into the plasma membranes of bacteria
resulting in the formation of pores on the plasma membrane
and leading to the inevitable death of prokaryotic and eukary-
otic pathogens (Bechinger 1997). Many cecropin analogs have
been designed and synthesized, and these peptides are as effec-
tive as or even more potent than their native molecules against
plant and animal bacterial pathogens and protozoa (Kadonon-
Okuda et al. 1995;Merrifield et al. 1995; Rodriguez et al. 1995;
Vunnam et al. 1995). Genes (cDNAs and genomic sequences)
encoding cecropins and their analogues have been cloned from
insects (van Hofsten et al. 1985; Tian et al. 2010), nematode
(Pillai et al. 2005), shrimp (Destoumieux et al. 1997; Chiou
et al. 2005), and vertebrates (Syvitski et al. 2005). By the use of
gene transfer technology, genes of cecropins and their ana-
logues have been used to produce transgenic plants (Jaynes
et al. 1987; Hassan et al. 1993; Jia et al. 1993; Huang et al.
1997; Osusky et al. 2000) with increased resistance to infection
by bacterial or fungal pathogens.
Fish diseases resulting from infection by bacterial, viral and
parasitic pathogens are one of the most severe bottlenecks in
aquaculture (Inglis and Hendrie 1993; Thune et al. 1993). For
the past few decades, efforts to control infectious diseases in
commercially important fish species have primarily depended
on employing antibiotics, developing suitable vaccines and
selecting fish strains with robust resistance to infectious path-
ogens. Although control of fish diseases by using antibiotics is
effective, the number of antibiotics approved for treating
diseased fish infected by bacterial pathogens is limited (Post
1987). Furthermore, the increasing number of antibiotic-
resistant pathogenic microorganisms in the aquatic environ-
ment challenges the strategy of using antibiotics to control fish
diseases (Fjalestad et al. 1993). While effective vaccines have
been developed for several important fish pathogens over the
past many years, the current vaccination practice is expensive,
laborious and time consuming (Fjalestad et al. 1993; Ganz
1999). The advantage of using vaccination technology is often
out-weighed by its labor-intensiveness. Genetic selection
based on traditional cross-breeding techniques is time-
consuming and the outcome is frequently unpredictable, and
sometimes disappointing due to lacking the desired genetic
traits. Therefore, more effective approaches for controlling
fish disease in aquaculture are highly desirable.
In vitro studies previously conducted in our laboratory
have shown that antimicrobial peptides such as cecropin B,
cecropin P1, pleurocidin and CF-17 peptide (a synthetic
cecropin B analogue) exhibited bactericidal activity to fish
bacterial pathogens such as Pseudomonas flourescens,
Aeromonas hydrophila and Vibrio anguillarum (Chiou et al.
2002; Sarmasik and Chen 2003; Chiou et al. 2006).
Furthermore, Chiou et al. (2002) showed in in vitro studies
that cecropin P1 and CF-17 peptide effectively inhibited the
replication of fish viruses such as infectious hematopoietic
necrosis virus (IHNV), viral hemorrhagic septicemia virus
(VHSV), snakehead rhabdovirus (SHRV) and infectious pan-
creatic necrosis virus (IPNV). Additionally, Jia et al. (2000)
demonstrated the enhanced resistance to bacterial infection in
fishwhichwere continuously transfusedwith a cecropin–melittin
hybrid peptide (CEME) and pleurocidin amide, a C-terminally
amidated form of the natural flounder peptide. These results
suggested that production of disease-resistant fish strain might
be achieved bymanipulatingAMPgenes. To test this hypothesis,
Sarmasik et al. (2002) introduced transgene constructs containing
prepro-cecropin B, procecropin B, mature cecropin B and
cecropin P1 into the embryos of medaka by electroporation.
The F2 transgenic medaka was subjected to bacterial challenges
at an LD50 dose with Pseudomonas fluorescens and V.
anguillarum , respectively. The resulting relative percent survival
(RPS) of the tested transgenic F2 fish ranged from 72% to 100%
against P. fluorescens and 25 % to 75 % against V. anguillarum ,
respectively.
To confirm the feasibility of producing disease-resistant
fish strains by manipulating antimicrobial peptide genes in
aquaculture fish species, we have transferred cecropin P1 or
CF-17 transgenes, under the control of a cytomegalovirus
(CMV) promoter, into rainbow trout by sperm-mediated gene
transfer method. A total of eight families of cecropin P1 and
nine families of CF-17 transgenic rainbow trout were
established and bred to all-male homozygous. In this article,
we report that the progeny of these transgene-expressing
rainbow trout strains exhibited resistance to infection by
Aeromonas salmonicida and IHNV.
Materials and Methods
Fish Stock and Transgene Constructs
Sperm and eggs of rainbow trout (Oncorhynchus mykiss )
were obtained from Troutlodge (Sumner, WA, USA) or
Roarding River Trout Hatchery (Scio, OR, USA). Fish from
embryos to adulthood were reared in tanks with flow through
fresh water (12–15 °C) in the John L. Fryer Salmon Disease
Laboratory of Oregon State University (Corvallis, OR, USA).
Fish were fed to satiety, once a day, with pelleted trout feed
(Melick Aqua Feeds, Catawissa, PA, USA).
Cecropin P1 transgene construct was provided by Dunham
et al. (2002). Briefly, the coding sequence of mature cecropin
P1 cDNA fused with the signal peptide sequence of catfish
immunoglobulin heavy chain (Ig) was cloned in frame into an
expression vector, pRC/CMV (5.5 kb; Invitrogen, Carlsbad,
CA, USA) under the control of a CMV promoter (Fig. 1). CF-
17 transgene construct was constructed by replacing sequence
of cecropin P1 with a synthetic gene of cecropin analog
(Fig. 1).
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Production of Transgenic Fish
Sperm was collected dry from reproductive mature males and
kept at 4 °C until use. Trout sperm can remain un-activated by
making one to four dilutions with phosphate buffered saline
(PBS: 8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2HPO4, 0.24 g/l,
KH2PO4, pH 7.6). Mix 300 μl of sperm (usually ~10
10 sperm/
ml) gently into 600 μl of linearized transgene construct (about
96 μg in PBS) in a cuvette to obtain 103 to 104 DNA
molecules/sperm. The mixture was electroporated in a “Cell-
Porator” (BRL, Rockville, MD, USA) under the following
condition: resistance, low; capacitance, 1,180 μF; voltage,
300 V; pulses, 2. After electroporation, sperm samples were
kept on ice for 10 min to revive, and then added dropwise to
500 eggs in a 1-l container. The eggs were swirled around
several times, left at room temperature for 5 min and then
activated with water. The fertilized eggs were poured into
hatching trays and dead eggs were removed by 48 h after
fertilization. The hatched fry were reared to adulthood for
genotyping for the presence of the transgene.
Genomic DNA samples were isolated from a small piece of
fin tissue collected from the caudal fin at 8 months of age and
screened for the presence of transgene sequence by polymer-
ase chain reaction (PCR) amplification and Southern blot
hybridization of the PCR products (Chen et al. 1993). The
primer sequences for amplification of cecropin P1 and CF-17
transgenes are listed in Table 1. The positive fish were referred
to as P1 transgenic individuals. After reproductive maturation,
these fish were crossed with non-transgenic counterparts to
produce F1, F2 and F3 heterozygous transgenic fish for disease
challenge studies.
Determination of Transgene Expression
Expression of cecropin P1 transgene or CF-17 transgene in the
individual F1, F2 or F3 transgenic fish was determined by
reverse transcription (RT)-PCR analysis. Total RNA samples
were isolated from tissues of liver, muscle and spleen of
transgenic individuals using Trizol reagent according to the
manufacturer’s protocol (Invitrogen). To confirm that RNA
samples were free of DNA contamination, RNA samples were
used as templates for direct PCR amplification of β-actin
sequence without RT. One microgram of total RNA from
transgenic or non-transgenic fish was reverse transcribed
using SuperScript III reverse transcriptase in a 20-μl reaction
volume containing 100 ng oligo-dT, 1 mM dNTP, 5 mMDTT,
1× reaction buffer, 1 unit of RNasin (Promega, Wisconsin,
USA), and 1 μl of Superscript III reverse transcriptase
according to the manufacture’s protocol (Invitrogen). After
RT, 1 μl of RT mix was used for the subsequent PCR ampli-
fication in a volume of 50 μl containing 200 μM dNTP,
1.5 mM MgCl2, 0.3 μM each gene specific primer and 1.25
units of Taq DNA polymerase (New England Biolaboratories,
Massachusetts, USA). The amplification profile contained the
following cycles: 1 cycle of 95 °C for 3 min, 40 cycles of
95 °C for 15 s, desired annealing temperature for 15 s, and
72 °C for 30 s. The PCR products were analyzed by electro-
phoresis on 1.2 % agarose gels.
Histological Examination
Rainbow trout fry were infected with A. salmonicida or
IHNV-RB, and the morbid fry were collected, euthanized
and fixed in 10 % buffered formalin (10 % formalin, 33 mM
sodium phosphate monobasic monohydrate, 46 mM sodium
phosphate dibasic heptahydrate). The fixed samples were
embedded in Paraplast paraffin (Oxford Labware), and sliced
sagittally into 6-μm sections. The sections were placed on
glass slides and stained with hematoxylin and eosin.
Pathogen Challenge Studies
Single colony of A. salmonicida was inoculated into 50 ml of
3 % tryptic soy broth (BD, Franklin Lakes, NJ, USA) contain-
ing 1%NaCl (TSB) and grew at 20 °C overnight. Then, 5ml of
the bacterial cells from the overnight culture was inoculated
into 250 ml of fresh TSB the next day and grew for an
additional 4 h at 20 °C until reaching mid-log phase. The
concentration of bacteria was determined by direct cell counting
using a hemocytometer. Fresh IHNV stock was prepared and
titer determined following the method described previously
(Engelking and Leong 1981), and stored at 4 °C until use.
Three groups each of non-transgenic, F2 or F3 heterozy-
gous transgenic fish (30 fish per each, 1–2 g/fish) were used in
the challenge studies with A. salmonicida at the dose of 5×
105 colony forming unit (cfu)/ml or IHNV at the dose of 5×
105 plaque forming unit (pfu)/ml. The challenge studies were
conducted in 25-l tanks. On the day of challenge experiment,
water in each tank was drained completely and fish were
stressed for 30 s. Immediately after stressing, 1 l of water
containing appropriate concentration of either bacteria or virus
Fig. 1 a Structures of transgene constructs used to produce transgenic
rainbow trout. b Amino acid sequences of porcine cecropin P1 and the
synthetic cecropin analogue, CF-17. CMV cytomegalovirus promoter re-
gion, IgG signal peptide sequence of catfish immunoglobulin heavy chain,
cecropin P1 porcine cecropin P1 gene, CF-17 synthetic cecropin analog
Mar Biotechnol (2014) 16:299–308 301
was added to each tank, and the fish were kept for an addi-
tional 6 h with constant aeration in the tank. At the end of
challenge with pathogens, aeration was stopped and air stones
removed. Large volume of constant running water is flooded
into each tank and fish were kept for another 4 to 6 weeks till
the end of experiment. At the end of the experiment, the total
numbers of survival fish were recorded and survival rates
calculated to determine the mortality of each family.
Production of All-Male Transgenic Fish
All-male transgenic trout was produced following the method
described by Parsons and Thorgarrd (1985). Briefly, eggs were
collected from non-transgenic females, exposed to Co60 gamma
radiation at a dose of 3×104R. The irradiated eggswere fertilized
with sperm of F3 heterozygous transgenic families. The diploidy
of the fertilized eggs was restored by suppressing the first cleav-
age division using hydrostatic pressure and the hatched fry were
reared to adulthood. The YY transgenic males were identified by
PCR amplification of cecropin P1 transgene and the male was
identified by PCR amplification of the Y chromosome specific
sequence (Brunelli et al. 2008) using oligonucleotide primers
listed in Table 1.
Results
Production, Identification and Characterization of Cecropin
P1 and CF-17 Transgenic Rainbow Trout
Linearized cecropin P1 and CF-17 transgenes were transferred
into rainbow trout via the sperm-mediated gene transfer meth-
od as described in Materials and Methods. The presence of
transgenes in P1 presumptive transgenic animals were deter-
mined by PCR amplification of the genomic DNA isolated
from fin clips (Fig. 2). About 30 % of the presumptive P1
transgenic animals were determined to carry cecropin P1
transgene and 25 % of the presumptive transgenic animals
carried CF-17 transgene, respectively. At reproductive matu-
ration, each P1 transgenic fish was mated with counterpart
non-transgenic fish to establish F1 founder families. A total of
eight founder heterozygous transgenic families carrying
cecropin P1 transgene and nine families carrying F-17 trans-
gene were established. Each family of the founder fish was
mated to non-transgenic fish to establish F2 and F3
generations.
To detect the expression of cecropin P1 or CF-17 transgene
in F1, F2 and F3 generations of heterozygous transgenic prog-
eny, total RNA samples isolated from tissues of liver, muscle
and spleen were subjected RT-PCR analysis. Figure 3 shows
the representative results of cecropin P1 transgene expression
in three randomly chosen F1 transgenic families. Transgene
mRNAswere detected in tissues of liver, muscle and spleen of
all eight families of cecropin P1 and nine families of CF-17
fish. To determine whether the expression of cecropin P1
transgene in transgenic fish will affect their growth perfor-
mance when compared to the non-transgenic fish, the body
lengths of several families of F1 heterozygous transgenic
progeny were compared with their non-transgenic counter-
parts. The representative result of one family is shown in
Fig. 4. In this comparison, the average size of non-
transgenic fish ranged about 16.0 g and that of transgenic fish
ranged about 15.4 g. These results might suggest the expres-
sion of cecropin P1 transgene in the transgenic fish family
might not affect their growth performance when compared to
non-transgenic fish.
Challenge Studies with A. salmonicida and IHNV
The antimicrobial activities of F2 and F3 heterozygous
transgneic progeny were determined by challenging with a
bacterial pathogen, A. salmonicida , at a dose of 5×105 cfu/ml
and a viral pathogen, IHNV, at a dose of 5×105 pfu/ml. In the
challenge studies with A. salmonicida , the cumulative
Table 1 Obligonucleotide
primers used in this study Primer no. Nucleotide sequence Target gene
TTC757 [Fd]: 5′-TCGTACGAGACATCAAGGAG-3′ β-Actin
TTC758 [Re]: 5′-AGGAAGGAGGGCTGGAAGAG-3′
TTC921 [Fd]: 5′-CACCAAAATCAACGGGACTT-3′ Cecropin P1 transgene
TTC922 [Re]: 5′-TACTCAGACAATGCGATGC-3′
TTC955 [Fd]: 5′-GCGTGGATTGCGGTTTGACT-3′ CF-17 transgene
TTC956 [Re]: 5′-ATAAGAGAGCAGGGCGAGGA-3′
TTC1251 [Fd]: 5′-GCCTGCTCCTGCTCCTCGCC-3′ mRNA of cecropin P1
TTC1249 [Re]: 5′-CTGGATGGCGATGGCGATGC-3′
TTC1310 [Fd]: 5′-TCTCTACCAGCCTGCTCCTG-3′ mRNA of CF-17 transgene
TTC1311 [Re]: 5′-CTAGAGGGCTTGTCCCACC-3′
TTC1367 [Fd]: 5′-TTCATATGCCAGGCTCAACA-3′ Y chromosome specific sequence
TTC1368 [Re]: 5′-GCTAATGGACGACGCTTTTC-3′
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mortality of control fish ranged 80–85 %, but the cumulative
mortalities of different families of F2 and F2 cecropin P1
transgenic progeny ranged 12–40 %, except for the family
of U6#768 where the mortality was similar to that of the
control fish (Table 2). When non-transgenic control fish were
challenged with IHNV at the dose of 5×105 pfu/ml, the
cumulative mortality ranged 82–83 %, but the cumulative
mortalities of F2 and F3 cecropin P1 transgenic families
ranged 4–25 %, except for the family of S8#505 where the
mortality was indistinguishable from that of the non-
transgenic fish (Table 3). Results of challenge studies of
different F3 heterozygous CF-17 transgenic families with A.
salmonicida and IHNVare presented in Table 4. By compar-
ing the cumulative mortalities of non-transgenic control fish
with different heterozygous families of CF-17 transgenic fish,
all nine families of heterozygous CF-17 transgenic fish
showed significant resistance to infection by IHNV. Similar
results were observed in challenge studies with A.
salmonicida except families 773 and 900 where challenge
studies were not conducted.
The typical pathological signs were observed in morbid
transgenic and non-transgenic fry challenged with A.
salmonicida and IHNV. As shown in Fig. 5, morbid fry
challengedwith A. salmonicida displayed typical pathological
signs including lesion of skin ulcers. Microscopically, focal
Aeromonas samonicida microcolonies were present in multi-
ple tissues, including liver, kidney and heart. When swabs
taken sterilely from the kidney of morbid fry were plated on
tryptone soy agar medium and cultured at 22 °C, the resulting
colonies uniformly showed typical features of Aeromonas
samonicida with convex morphology and brown pigment.
While typical pathological signs including distended abdo-
men, petechial hemorrhages and exophthalmos were observed
in morbid fry challenged with IHNV, microscopic observation
revealed extensive necrosis in the internal organs including
kidney and liver (Fig. 6).
Development of All-Male Transgenic Rainbow Trout
All-male homozygous cecropin P1 transgenic fish strains
were bred from F3 heterozygous transgenic fish by using the
technique of androgenesis developed by Parsons and
Thorgarrd (1985). Eight families (S7#375-F073, S9#659-
F180, S9#746-F509, U6#768-G410, S8#505-G231, S7#342-
F695, A12-944 and A13-831) of all-male homozygous
cecropin P1 transgenic fish were successfully bred.
Although female transgenic fish were also produced in this
operation, these fish were discarded since these fish produced
poor quality eggs according to studies by Scheerer et al.
Fig. 2 Identification of transgenic rainbow trout by PCR amplification of
genomic DNA from F1 heterozygous transgenic individuals. a Detection
of cecropin P1 transgene sequence. a PCR products; b hybridization
signals of PCR products. Lanes 1–6 , DNA samples from presumptive
transgenic fish; lane 7 , DNA of cecropin P1 transgene construct; lanes 8–
9 , DNA from non-transgenic control fish. b Detection of CF-17 trans-
gene sequence. a PCR products; b hybridization signals of PCR prod-
ucts. Lanes 1 and 3–6 , DNA samples from presumptive transgenic fish;
lane 2 , DNA sample from non-transgenic control fish; lane 7 , DNA of
CF-17 transgene construct
Fig. 3 Expression of cecropin P1 transgene in transgenic rainbow trout.
Total RNA samples were prepared from the liver, muscle and spleen
tissues of cecrpoin P1 transgenic fish (heterozygous F1 generation), and
were subjected to RT-PCR analysis for detection of cecropin P1 transcript
following the method described in Materials and Methods. 3736, 3956
and HO4389 are randomly selected F1 heterozygous transgenic fish. L
liver, M muscle, S spleen; +, plasmid DNA contains cecropin P1 se-
quence for positive control in PCR; −, PCR reaction in the absence of
cecropin P1 DNA
Fig. 4 Body size distribution of transgenic and non-transgenic fish. The
body sizes of cecropin P1 heterozygous transgenic fish (F1 generation)
and their non-transgenic sibling controls were measured and grouped into
different size classes
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(1991). The expression of cecropin P1 transgene in heart,
liver, muscle and spleen tissues of six selected homozygous
families was confirmed by RT-PCR analysis. As shown in
Fig. 7, various levels of cecropin P1 mRNAwere detected in
these tissues. Two selected families (namely S7#375-F073
and S7#659-F180) of cecropin P1 homozygous all-male fish
were outcrossed to non-transgenic females and their hetero-
zygous progeny were subjected to challenge studies with A.
salmonicida at the concentrations of 1×105 and 5×105 cfu/
ml, and the results of the challenge studies were presented in
Fig. 8. Persistent resistant characteristic to A. salmonicida
infection was observed in the heterozygous fish derived from
both homozygous families out cross to non-transgenic fish.
Discussion
In aquaculture industry worldwide, bacterial and viral diseases
result in tremendous economic losses annually. Current strat-
egies to control these diseases consist of prophylaxis such as
vaccination with inactivated pathogens or recombinant vac-
cines, medication with chemicals or antibiotics, and eradica-
tion of infected populations. Although effective vaccines have
Table 2 Mortalities of F2 and F3 heterozygous cecropin P1 transgenic
fish challenged with A. salmonicida
Families % Mortality (mean±SD)










For each family, challenge was conducted with 30 fish/family (1–2 g
body weight)in triplicates and the dose of A. salmonicida (5×105 cfu/ml)
used in each challenge study brings about 80 % mortality in non-trans-
genic fish
Table 3 Mortalities of F2 and F3 heterozygous cecropin P1 transgenic
fish challenged with IHNV
Families % Mortality (mean±SD)










For each family, challenge was conducted in 30 fish/family (1–2 g body
weight)in triplicates and the dose of IHNV (5×105 pfu/ml)used in each
challenge study brings about 80 % mortality in non-transgenic fish
Table 4 Mortalities of F3 heterozygous CF-17 transgenic rainbow trout
challenged with A. salmonicida or IHNV












For each family, challenge was conducted with 30 fish/family (1–2 g
body weight)in triplicates and the dose of A. samonicida (5×105 cfu/
ml)or IHNV(5×105 pfu/ml)in each challenge study brings about 80 %
mortality in non-transgenic fish
– not tested
Fig. 5 Fry of non-transgenic rainbow trout infected with A. salmonicida
exhibited typical pathological signs. Morbid fry showed typical lesion of
skin ulcer (a). Microscopically, focal A. salmonicida microcolonies
(indicated by red circles) were present in multiple tissues, including liver
and kidney (b). Occasionally, the bacteria microcolonies were observed
in the heart (inset in b). Swabs taken sterilely from the kidney of morbid
fry were plated on tryptone soy agar (TSA) and incubated at 22°C. The
colonies uniformly showed typical features of A. salmonicida with con-
vex morphology and brown pigment (c)
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been developed for selective important fish pathogens over
the past decades, the economic cost of developing vaccines
and the labor intensiveness of vaccination practice frequently
out-weigh the economic benefits. Furthermore, the potential
risk of residual levels of antibiotics left in the flesh of fish and
the selection of antibiotic-resistant bacterial strains in the
aquatic environment argues against the benefit of using anti-
biotics to control fish diseases. If a genetic trait that will confer
fish to be resistant to bacterial, viral or parasitic infection can
be identified, manipulation of this genetic trait by transgenesis
may present a unique opportunity to resolve the problem of
disease outbreak in aquaculture.What genetic trait may confer
fish resistant to infection by pathogens?
It has long been recognized that both innate and adaptive
immunity systems are required for fish and higher animals to
overcome infection by microbial pathogens. While adaptive
immunity can protect the host from infection by specific
microbial pathogens, it usually requires a longer period of
time for the host to develop antigen-specific antibodies and
immunologic memory against the specific pathogen. Since
fish are living under a lower temperature environment com-
pared to mammals, it will require a longer period of time to
develop adaptive immunity to control the initial phase of
infection by microbial pathogens (Boman 1995; Bonizzi and
Karin 2004). The innate immunity system could serve as the
first line of defense to eliminate primary infection by micro-
bial pathogens because the host produces antimicrobial pep-
tides or other small molecular weight compounds with anti-
microbial activities within hours upon exposure to pathogens
(Boman 1995). Since the identification of the first insect
antimicrobial peptides, cecropins, a large body of similar
antimicrobial peptides has been identified in a wide variety
of organisms throughout the animal kingdom (Hultmark et al.
1980; Boman and Hultmark 1987; Destoumieux et al. 1997;
Chiou et al. 2005; Pillai et al. 2005; Syvitski et al. 2005). In
vitro and in vivo studies showed that these peptides possess
activities against a broad spectrum of fish bacterial viral
pathogens (Boman 1995; Hancock and Lehrer 1998; Jia
et al. 2000; Chiou et al. 2002; Sarmasik et al. 2002). Studies
have also been reported that transfer of functional cecropin B
gene into plants resulted in the production of transgenic plants
with elevated resistance to bacterial pathogens (Jaynes et al.
1987; Hassan et al. 1993; Jia et al. 1993; Huang et al. 1997;
Osusky et al. 2000). These results suggest that transgenic
manipulation of antimicrobial peptide genes may lead to the
production of fish strains with elevated resistance to bacterial
and viral pathogens.
To test this hypothesis, Sarmasik et al. (2002) introduced
transgenes of pre-pro-cecropin B, pro-cecropin B, mature
cecropin B and cecropin P1 driven by a CMV promoter into
Japanese medaka (Orizias latipas ). The resulting F2 transgen-
ic progeny displayed significant resistance to P. fluorescens
and V. anguillarum in repeated challenge studies. Like trans-
genic plants expressing antimicrobial peptide genes (Jaynes
Fig. 6 Fry of non-transgenic
rainbow trout infected with IHNV
exhibited typical pathological
signs. a Morbid fry showed





necrosis was observed in the
internal organs, including kidney
(b) and liver (c)
Fig. 7 Detection of cecropin P1 transgene expression in homozygous
transgenic fish by RT-PCR analysis. a RT-PCR products of cecropin P1
transgene; b RT-PCR product of β-actin gene. Total RNA samples were
prepared from tissues of heart, spleen, muscle and liver and subjected to
RT-PCR analysis for the expression of cecropin P1 transgene following
methods described in Materials and Methods. H heart, S spleen, M
muscle, L liver
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et al. 1987; Hassan et al. 1993; Jia et al. 1993; Huang et al.
1997; Osusky et al. 2000), transgenic medaka expressing
cecropin B or cecropin P1 transgene displayed resistant char-
acteristic to common fish bacterial pathogens.
Will an aquaculture important fish species exhibit the sim-
ilar resistant characteristic to common fish bacterial pathogens
if a cecropin B or cecropin P1 transgene is introduced into the
fish by transgenesis? To answer this question, we produced
transgenic rainbow trout carrying cecropin P1 or CF-17 trans-
gene fused to the CMV promoter by sperm mediated gene
transfer method. PCR analysis of the presumptive P1 trans-
genic fish showed that about 30 % of the presumptive P1
transgenic animals carried the cecropin P1 transgene and
25% carried the CF-17 transgene. These results are consistent
with those reported by other investigators (Powers et al. 1992;
Symonds et al. 1994; Sin et al. 2000; Lu et al. 2002). A total of
eight F1 founder heterozygous transgenic families carrying
cecropin P1 transgene and nine F1 heterozygous families
carrying CF-17 transgene were established, respectively.
Results of RT-PCR analysis confirmed the expression of
cecropin P1 and CF-17 transgenes in F1, F2 and F3 heterozy-
gous transgenic progeny.
Fish digestive tract, like the digestive tract of human, is
inhabited by large numbers of pathogenic and non-pathogenic
microorganisms (Cummings and Macfarlans 1997; Guarner
and Malagelada 2005; Ray et al. 2012; Sanchez et al. 2012).
Many of these non-pathogenic microorganisms contribute
greatly to the digestion of foods, supplying vitamin B complex
and other essential nutrients, and enhancing absorption of
nutrients by the fish gut (Ray et al. 2012; Sanchez et al.
2012). Since antimicrobial peptides possess bactericidal ac-
tivity to a large spectrum of microorganisms, it is conceivable
that cecropin P1 and CF-17 transgene expressed in the trans-
genic fish may kill the beneficial microorganisms in the gut
and thus affect the growth performance of the fish. When the
patterns of body size distribution of several F1 heterozygous
transgenic families expressing cecropin P1 transgene were
compared to that of non-transgenic siblings, the patterns of
body size distribution of transgenic fish were not significantly
different from to those of the non-transgenic fish. These
results suggest that the expression of cecropin P1 transgene
in the transgenic fish may not affect the population of the
beneficial microorganisms inhabiting in the fish digestive
system. Similar observation has also been reported by
Dunham et al. (2002) in F1 heterozygous transgenic channel
catfish (Ictalurus punctatus ) expressing cecropin transgenes.
Types of pathogens, routes of pathogen entry, and the
virulence of pathogens are three critical factors in pathogen
challenge studies (Michel 1980; Adams et al. 1987). Since A.
salmonicida and IHNV are two well-recognized aggressive
pathogens infecting salmonid fish species, we chose these two
organisms as target pathogens for the challenge studies to
determine the antimicrobial activity of cecropin P1 and CF-
17 transgenic fish. In the challenge studies, A. salmonicida at
the concentration of 5×105 cfu/ml or IHNVat the concentra-
tion of 5×105 pfu/ml were introduced into fish of 1–2 g body
weight by immersion because this method could provide the
most natural route of pathogen entry into the fish (McCarthy
1983; Hjeltnes et al. 1989). In repeated challenge studies,
while exposure of non-transgenic fish to 5×105 cfu/ml of A.
salmonicida or 5×105 cfu/ml of IHNV resulted in about 80 %
of cumulative mortality, exposure of F2 or F3 transgenic
families of cecropin P1 transgenic fish to A. salmonicida
brought about 10–40 % cumulative mortalities and 4–20 %
cumulative mortalities to IHNV. Similar degrees of protection
from infection by both pathogens were also observed in CF-17
transgenic families. It is of interesting to note that while most
families of F2 and F3 cecropin P1 transgenic fish displayed
resistant characteristic to both pathogens, family U6#768
failed to show resistant characteristic to A. salmonicida and
family S8#505 failed to display resistant characteristic to
IHNVeven though both families expressed cecropin P1 trans-
gene. The reason for this dichotomy requires further investi-
gation. Nevertheless, the overall results from the current study
are in good agreement with the in vitro studies reported by
Chiou et al. (2002) where they reported that synthetic cecropin
B and CF-17 were effective in killing A. salmonicida and
various fish RNA viruses including IHNV.
In summary, we demonstrated in this study the production
of strains of stable transgenic rainbow trout expressing
cecropin P1 or CF-17 transgene by sperm-mediated gene
transfer method. These transgenic fish displayed elevated
resistant characteristic to infection by A. salmonicida and
IHNV. By employing the technique of androgenesis, homo-
zygous all-male (YY) transgenic families have been bred in
one generation; and these transgenic stocks can be preserved
via sperm cryopreservation. Dunham et al. (2002) reported
previously the production of transgenic channel catfish
(Ictalurus punctatus ) harboring cecropin B transgenes
Fig. 8 Percent survival of heterozygous cecropin P1 transgenic fish
derived from all-male homozygous fish challenged with Aeromonas
salmonicida. Triplicate families of heterozygous transgenic fish progeny
(50 fish/family of 0.4–0.5 g body weight) and non-transgenic controls
were challenged with A. salmonicida at doses of 1×105 and 5×105 cfu/
ml as described in Materials and Methods. Morbid fish were collected
daily over a period of 2 weeks post-challenge with the pathogen
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exhibiting elevated resistant to bacterial pathogen in the F1
generation. Therefore, results presented in this paper, together
with those of Dunham et al. (2002), clearly point to the possi-
bility of producing disease-resistant fish strains for aquaculture
by transgenic manipulation of antimicrobial peptide genes.
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